CA 20319/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1980	1
1982	1
1983	2
1984	4
1985	4
1986	5
1987	5
1988	1
1989	3
1990	6
1991	8
1992	4
1993	7
1994	1
1995	2
1996	1
1997	1
2002	2
2003	3
2004	1
2005	1
2006	2
2007	2
2008	2
2011	2
2013	2
2014	1
2024	0

1

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Forastiere AA, et al. N Engl J Med. 2003 Nov 27;349(22):2091-8. doi: 10.1056/NEJMoa031317. N Engl J Med. 2003. PMID: 14645636 Free article. Clinical Trial.

2

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.

Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM. Goodman GE, et al. J Clin Oncol. 1990 Jan;8(1):39-47. doi: 10.1200/JCO.1990.8.1.39. J Clin Oncol. 1990. PMID: 2153194 Clinical Trial.

3

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

Yao S, Sucheston LE, Zhao H, Barlow WE, Zirpoli G, Liu S, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB. Yao S, et al. Pharmacogenomics J. 2014 Jun;14(3):241-7. doi: 10.1038/tpj.2013.32. Epub 2013 Sep 3. Pharmacogenomics J. 2014. PMID: 23999597 Free PMC article. Clinical Trial.

4

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.

Albain KS, Green S, LeBlanc M, Rivkin S, O'Sullivan J, Osborne CK. Albain KS, et al. Breast Cancer Res Treat. 1992;22(3):273-84. doi: 10.1007/BF01840840. Breast Cancer Res Treat. 1992. PMID: 1391993

5

High-dose cisplatin in disseminated melanoma: a comparison of two schedules.

Mortimer JE, Schulman S, MacDonald JS, Kopecky K, Goodman G. Mortimer JE, et al. Cancer Chemother Pharmacol. 1990;25(5):373-6. doi: 10.1007/BF00686241. Cancer Chemother Pharmacol. 1990. PMID: 2306798

6

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Albain KS, et al. J Clin Oncol. 1991 Sep;9(9):1618-26. doi: 10.1200/JCO.1991.9.9.1618. J Clin Oncol. 1991. PMID: 1651993 Clinical Trial.

7

Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.

Bukowski RM, Wolf M, Kulander BG, Montie J, Crawford ED, Blumenstein B. Bukowski RM, et al. Cancer. 1993 Apr 15;71(8):2631-8. doi: 10.1002/1097-0142(19930415)71:8<2631::aid-cncr2820710831>3.0.co;2-g. Cancer. 1993. PMID: 7680950 Clinical Trial.

8

Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study.

Alberts DS, Mason NL, O'Toole RV, Hilgers RD, Rivkin SE, Boutselis JG, Pugh RP, Vaitkevicius VK, Green JB, Oishi N. Alberts DS, et al. Gynecol Oncol. 1987 Feb;26(2):193-201. doi: 10.1016/0090-8258(87)90273-3. Gynecol Oncol. 1987. PMID: 3542743 Clinical Trial.

9

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

Gandara DR, Crowley J, Livingston RB, Perez EA, Taylor CW, Weiss G, Neefe JR, Hutchins LF, Roach RW, Grunberg SM, et al. Gandara DR, et al. J Clin Oncol. 1993 May;11(5):873-8. doi: 10.1200/JCO.1993.11.5.873. J Clin Oncol. 1993. PMID: 8387576 Clinical Trial.

10

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.

Hazuka MB, Crowley JJ, Bunn PA Jr, O'Rourke M, Braun TJ, Livingston RB. Hazuka MB, et al. J Clin Oncol. 1994 Sep;12(9):1814-20. doi: 10.1200/JCO.1994.12.9.1814. J Clin Oncol. 1994. PMID: 8083705 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year